4
Changes in Ownership
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-23-059274
Options or other derivatives
- Director acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lisicki Robert Director | 2023-07-23 | Grant or award · Stock options | +75,000 | 75,000 | D | ||
Loading xslF345X05/ownership.xml…